Menu

Cartesian Therapeutics (RNAC)

RNAC

RNAC · NASDAQ

$6.41−0.08 (−1.23%)

At close on Nov 3

Overview Earnings Financials Ownership

Overview

Financial statement

An agent-based financial analysis engine for public markets.

© 2026 FolioSheet. All rights reserved.

Company

Legal

Support